Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.300
-0.070 (-5.11%)
At close: Feb 21, 2025, 4:00 PM
1.379
+0.079 (6.10%)
After-hours: Feb 21, 2025, 7:58 PM EST
Psyence Biomedical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Selling, General & Admin | 2.79 | 1.8 | 1.63 | 2.15 |
| Research & Development | 0.43 | 0.95 | 1.61 | 0.17 |
| Operating Expenses | 3.22 | 2.75 | 3.23 | 2.32 |
| Operating Income | -3.22 | -2.75 | -3.23 | -2.32 |
| Interest Expense | -0.03 | -0.05 | - | - |
| Interest & Investment Income | 0 | 0 | 0 | - |
| Currency Exchange Gain (Loss) | 0.11 | -0 | 0.03 | -0 |
| Other Non Operating Income (Expenses) | 0.2 | -4.69 | - | - |
| EBT Excluding Unusual Items | -2.93 | -7.5 | -3.21 | -2.32 |
| Other Unusual Items | -43.66 | -43.66 | - | - |
| Pretax Income | -46.59 | -51.16 | -3.21 | -2.32 |
| Net Income | -46.59 | -51.16 | -3.21 | -2.32 |
| Net Income to Common | -46.59 | -51.16 | -3.21 | -2.32 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | - |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | - |
| Shares Change (YoY) | 239.30% | 30.34% | - | - |
| EPS (Basic) | -76.91 | -588.74 | -48.10 | - |
| EPS (Diluted) | -76.91 | -588.74 | -48.10 | - |
| Free Cash Flow | -2.89 | -2.95 | -1.59 | -1.74 |
| Free Cash Flow Per Share | -4.76 | -33.96 | -23.88 | - |
| EBITDA | - | -2.75 | - | - |
| D&A For EBITDA | - | 0 | - | - |
| EBIT | -3.22 | -2.75 | -3.23 | -2.32 |
Source: S&P Capital IQ. Standard template.
Financial Sources.